Pharmacyclics Shares Surge on Drug Approval Application

Pharmacyclics Inc. surged to its highest value ever after filing for U.S. approval of a blood cancer drug that is being developed with Johnson & Johnson.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.